New Delhi, Dec 7
Vaccine manufacturing major Serum Institute of India (SII) on Monday said it has applied to Drugs Controller General of India (DCGI) for emergency use authorisation for its COVID-19 vaccine Covishield.
किसान आंदोलन हुआ तेज, गुस्साए किसानों ने निकाली भड़ास
The Pune-based company has collaborated with Oxford University and pharmaceutical company Astra Zeneca for making the vaccine and is conducting trials in India.
ऐसे लोगों से रहें सावधान पलक झपकते ही कर देंगे ऐसा काम जो पड़ेगा महंगा
“As promised, before the end of 2020, @SerumInstIndia has applied for emergency use authorisation for the first made-in-India vaccine, Covishield,” SII CEO Adar Poonawala said in a tweet.
क्या कहते हैं आपके सितारे आज का राशिफल 6 दिसंबर 2020
He further said: “This will save countless lives, and I thank the Government of India and Sri @narendramodi ji for their invaluable support.”
Last week, Pfizer India said it has applied to India’s drug regulator DCGI for emergency-use authorisation for its COVID-19 vaccine, after the company’s parent received clearance for the treatment from Britain and Bahrain.
-Nav Gill/Agency
